ANAMBRA GOVERNMENT DISSOLVES NKWO UMUEZE MARKET LEADERSHIP OVER DEFIANCE OF MONDAY TRADING DIRECTIVE. (PHOTOS). #PRESS RELEASE

Image
 Anambra Government Dissolves Nkwo Umueze Market Leadership Over Defiance of Monday Trading Directive By Ebele Iyke Odili/Amaka Isikala  The Anambra State Government has dissolved the caretaker committee of Nkwo Umueze Market for failing to comply with the state’s directive mandating full commercial activities on Mondays. The dissolved committee, led by Mr. Onyeka Ekemezie, has been relieved of its duties with immediate effect.  The former chairman and members of the committee have consequently ceased to function as the recognized leadership of the market. The decision follows a clear policy position of Governor Charles Chukwuma Soludo that no market in the state should remain closed on Mondays under any guise.  The Governor had earlier warned that any market leadership found enforcing or encouraging continued closure would be dissolved in the interest of economic stability and public order. It would be recalled that the Monday sit-at-home, previously imposed by the ...

KENYA HAILS FIRST ROLLOUT OF HIV PREVENTION DRUG LENACAPAVIR. (PHOTO).


 Kenya hails first rollout of HIV prevention drug Lenacapavir


Kenya began administering the first dose of a groundbreaking HIV prevention drug in a Nairobi slum on Thursday.


Lenacapavir, taken twice a year, has been shown to reduce the risk of HIV transmission by more than 99.9 percent, though it is technically a chemical drug rather than a vaccine because it does not train the immune system.


"Today is a moment of hope for thousands of Kenyan families," Health Minister Aden Duale said during the rollout, AFP reported.


Kenya was among nine African countries selected last year to introduce lenacapavir, which has already been introduced in South Africa, Eswatini and Zambia since December.


There are roughly 1.3 million people living with HIV in Kenya, with the highest burden among those aged 15 to 24.


‘Renewed strength’


"Many of our young people still face the risk of infection... this innovation gives us renewed strength in our national fight against HIV," Duale, said adding that the drug will be free to those receiving it.


Last week, Kenya received its first batch of 21,000 doses through a deal with lenacapavir's manufacturer, Gilead Sciences, and the Global Fund to Fight AIDS.


Lenacapavir offers greater privacy compared to regularly visits to health clinics for treatment, said Carol Njomo, a community health worker in Nairobi's Kawangware area, where the first doses were administered.


"This is an added protection," said Samson Mutua, 27, the first person to receive the injection.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

TINUBU ANNOUNCES ARRIVAL OF 4 U.S ATTACK HELICOPTERS. (PHOTO).